Literature DB >> 22392001

Economic methods in the century trial--a comprehensive lifestyle modification study for managing coronary artery disease.

James R Langabeer1, Rigoberto Delgado, David Lairson, Nils P Johnson, K Lance Gould, Stefano M Sdringola.   

Abstract

While most studies assess the cost-effectiveness of treating acute coronary conditions, the Century Health Study for Cardiovascular Medicine (Century Trial) focuses on ameliorating coronary artery disease (CAD) through a comprehensive lifestyle modification program. This 1,300-patient phase III randomized study uses positron emission tomography for risk stratification, complemented with comprehensive educational and motivational therapy for patients with preclinical or established CAD. The Century Trial is in its second year of a five-year follow-up protocol, and it is one of the first to combine imaging technology and lifestyle modification as a way to improve patient behavior and health. In this article, we present the economic study design used in the Century Trial and provide considerable methodological detail to serve as reference for other researchers. We describe the cost and effect estimation methods as well as our analysis and uncertainty modeling plans. The study will incorporate quality-adjusted life years and use a societal perspective to measure both in-trial and lifetime costs through incremental cost-effectiveness ratios. The approach we follow should provide further evidence on the cost-effectiveness of comprehensive lifestyle modification programs in regressing coronary artery disease.

Entities:  

Mesh:

Year:  2012        PMID: 22392001     DOI: 10.1007/s12265-012-9355-x

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  20 in total

1.  AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association.

Authors:  R M Krauss; R H Eckel; B Howard; L J Appel; S R Daniels; R J Deckelbaum; J W Erdman; P Kris-Etherton; I J Goldberg; T A Kotchen; A H Lichtenstein; W E Mitch; R Mullis; K Robinson; J Wylie-Rosett; S St Jeor; J Suttie; D L Tribble; T L Bazzarre
Journal:  Circulation       Date:  2000-10-31       Impact factor: 29.690

Review 2.  Diets and cardiovascular disease: an evidence-based assessment.

Authors:  Parin Parikh; Michael C McDaniel; M Dominique Ashen; Joseph I Miller; Matthew Sorrentino; Vicki Chan; Roger S Blumenthal; Laurence S Sperling
Journal:  J Am Coll Cardiol       Date:  2005-05-03       Impact factor: 24.094

Review 3.  Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.

Authors:  Scott Ramsey; Richard Willke; Andrew Briggs; Ruth Brown; Martin Buxton; Anita Chawla; John Cook; Henry Glick; Bengt Liljas; Diana Petitti; Shelby Reed
Journal:  Value Health       Date:  2005 Sep-Oct       Impact factor: 5.725

4.  The role of risk stratification in the decision to provide upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: a cost-effectiveness analysis.

Authors:  Ruchira Glaser; Henry A Glick; Howard C Herrmann; Stephen E Kimmel
Journal:  J Am Coll Cardiol       Date:  2006-01-18       Impact factor: 24.094

5.  Mechanisms of progression and regression of coronary artery disease by PET related to treatment intensity and clinical events at long-term follow-up.

Authors:  Stefano Sdringola; Catalin Loghin; Fernando Boccalandro; K Lance Gould
Journal:  J Nucl Med       Date:  2006-01       Impact factor: 10.057

6.  A cost-analysis of adopting a healthful diet in a family-based obesity treatment program.

Authors:  Hollie A Raynor; Colleen K Kilanowski; Irina Esterlis; Leonard H Epstein
Journal:  J Am Diet Assoc       Date:  2002-05

7.  Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.

Authors:  Stephen J Nicholls; E Murat Tuzcu; Ilke Sipahi; Adam W Grasso; Paul Schoenhagen; Tingfei Hu; Kathy Wolski; Tim Crowe; Milind Y Desai; Stanley L Hazen; Samir R Kapadia; Steven E Nissen
Journal:  JAMA       Date:  2007-02-07       Impact factor: 56.272

8.  Health status predicts long-term outcome in outpatients with coronary disease.

Authors:  John A Spertus; Philip Jones; Mary McDonell; Vincent Fan; Stephan D Fihn
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

9.  Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.

Authors:  D Ornish; S E Brown; L W Scherwitz; J H Billings; W T Armstrong; T A Ports; S M McLanahan; R L Kirkeeide; R J Brand; K L Gould
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

10.  A randomised controlled trial of a community-based healthy lifestyle program for overweight and obese adolescents: the Loozit study protocol.

Authors:  Vanessa A Shrewsbury; Janice O'Connor; Katharine S Steinbeck; Kate Stevenson; Anthea Lee; Andrew J Hill; Michael R Kohn; Smita Shah; Siranda Torvaldsen; Louise A Baur
Journal:  BMC Public Health       Date:  2009-04-29       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.